Clinical Trial Stem Cells

Clinical Trials Stem Cells

At ITRT, we are leading the clinical research worldwide in Regenerative Therapy, proving the unprecedented efficacy and safety of Cultured Mesenchymal Stem Cells in diverse pathologies.
Our 22 clinical trials are the world’s largest body of scientific evidence on regeneration, reason why we have been quoted more than 1,800 times in the most prestigious medical and scientific journals.

Stem cell therapy has become the way to treat and heal injuries that until the moment had no treatments. This is due to the fact that stem cells are incredibly capable of helping the body.

Our scientific background makes us the most authorized voice in the field of regenerative medicine and stem cells treatment.

The numerous clinical trials carried out since 2003 have shown unprecedented results that scientifically prove that thanks to the volume of millions of cells we apply,

it is possible to regenerate tissues that until now were considered unviable.

Completed clinical trials Stem Cells

Cultured Mesenchymal Stem Cells (C-MSC)

Ongoing clinical trials Stem Cells

Cultured Mesenchymal Stem Cells (C-MSC)

Completed Clinical Trials with PRP

Platelet-Rich Plasma (PRP)

Pre-Clinical Trials

ITRT has conducted clinical trials on animals to treat pathologies from the musculoskeletal system, which have been key to prove efficacy and safety of Cultured Stem Cell therapy in diverse pathologies.
 
Prior moving ahead to treat humans it is mandatory to prove the safety and efficacy in animals. In this sense, we have regenerated tendon, cartilage or nerves in sheep, horses, pigs or dogs.
 
 
Foto 2 Lab Banc Sang Teixits

Completed Pre-Clinical Trials Stem Cells

Cultured Mesenchymal Stem Cells (C-MSC)

Completed Pre-clinical Trials PRP

Platelet-Rich Plasma (PRP)

Blog

News

CLINICAL TRIAL ON XEROSTOMY (DRY MOUTH)

The scientific journal “Integrative Clinical Medicine” has published the feature “Treatment with mesenchymal stem cells for xerostomia: A…

Presentation in Costa Rica

On August 7, Dr. Robert Soler Rich, Medical Director of the ITRT, gave the presentation “Treatment with cultured…

ITRT proves for the first time that tendon can be regenerated with cultured mesenchymal stem cells

Data from the clinical trial, which has just been published in the prestigious American Journal of Sports Medicine,…